Part 2: Patients with Hepatitis B: Medical Comorbidities That Can Impact Treatment and Prompt the Provider to Switch

Launch Date
09/27/2021
Credit Amount
0.00 Expired
Credit Expires
09/27/2022

Faculty

Kimberly A. Forde, MD, PhD, MHS
Associate Professor of Medicine, Section of Hepatology, Department of Medicine
Temple University Hospital, Lewis Katz School of Medicine, Philadelphia, PA
Kimberly A. Forde, MD, PhD, MHS

Kimberly A. Forde, MD, PhD, MHS, is an Associate Professor of Medicine, in the Section of Hepatology, Department of Medicine, at the Temple University Hospital, Lewis Katz School of Medicine. Dr. Forde earned her Bachelor of Arts degree in Biology from Barnard College and her medical degree from Columbia University, College of Physicians and Surgeons. She completed her Internal Medicine Residency at New York Presbyterian Hospital (Columbia University), with subspecialty training in Gastroenterology and Hepatology, at the University of Pennsylvania where she also served as Chief Fellow. Dr. Forde’s research interests include the epidemiology of viral hepatitis and outcome assessment in patients with acute and chronic liver failure. Dr. Forde is a prolific writer, having authored more than 70 peer reviewed articles in high impact journals such as the New England Journal of Medicine, Gastroenterology and Hepatology. In addition to her research and teaching, she has served on several national committees, including the Clinical Research Committee of the American Association for the Study of Liver Diseases and the nominating Committee for the American Gastroenterological Society.

Christina M. Madison, PharmD, FCCP, AAHIVP
Founder and CEO, The Public Health Pharmacist, PLLC
Associate Professor of Pharmacy Practice, Roseman University of Health Sciences, College of Pharmacy, Las Vegas, NV
Christina M. Madison, PharmD, FCCP, AAHIVP

Christina Madison, PharmD, FCCP, AAHIVP, is the Founder and CEO of The Public Health Pharmacist, PLLC, a public health consulting firm. She is also an Associate Professor of Pharmacy Practice with Roseman University of Health Sciences and works as a clinical pharmacist specializing in public health with a focus on infectious communicable diseases. Dr. Madison maintains two active practice sites with Huntridge Family Clinic and Volunteers in Medicine of Southern Nevada (VMSN). She has been caring for those affected and infected with HIV for over 15 years in the Las Vegas Metropolitan area and has been credentialed with the American Academy of HIV Medicine since 2013. A trusted and valued health care professional who has been asked to share her clinical public health and infectious disease expertise with local, state, and international media outlets and non-governmental organizations.

Since January 2020, Dr. Madison has been featured in over 250+ on-air television appearances related to the pandemic and public health. Advocating for public health and the profession of pharmacy to improve the health and wellness of vulnerable populations and the underserved is her passion and mission.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credits

Statement of Need

As a result of often-delayed diagnosis and treatment, patients with Chronic Hepatitis B (CHB) are presenting at an older age and with more liver and non-liver comorbidities that can further complicate treatment. Keeping a watchful eye on patients’ use of over-the-counter medications, supplements, and prescription medications for comorbid disorders that may interact with their HBV antiviral treatment is imperative.

This CME Outfitters webcast focuses on how pharmacists can partner with patients to help them to better understand their HBV, as well as best practices for communicating and collaborating with health care professionals about patients’ HBV treatment plans, and how they might be impacted by medical comorbidities, in order to optimize patient outcomes.

Learning Objectives

At the end of this CME/CE activity, participants should be able to partner with patients with HBV and their HCPs to support therapeutic decision-making in the presence of renal and bone comorbidities.

Financial Support

Supported by an educational grant from Gilead Sciences, Inc.

Target Audience

Pharmacists

Credit Information

Pharmacists/Pharmacy Tech (ACPE) 0.5

This application-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit.
JA0007185-0000-21-159-H01-P

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Forde has no disclosures to report.

Dr. Madison reports that she is on the speakers bureau for Gilead Sciences, Inc. and Janssen Therapeutics.

Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:

  • Mae Ochoa, RPh (peer reviewer) has no disclosures to report
  • Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

Part 2: Patients with Hepatitis B: Medical Comorbidities That Can Impact Treatment and Prompt the Provider to Switch
Event Date: 09/27/2021